Showing results (271-280 of 339) with videos related to

Sort By:
Pageof 34
JAMA Oncology|July 17, 2015
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1Brooke E Howitt, Sachet A Shukla, Lynette M Sholl, et al.
Molecular Cell|December 22, 2018
USP1 Is Required for Replication Fork Protection in BRCA1-Deficient TumorsKah Suan Lim, Heng Li, Emma A Roberts, et al.
Oncotarget|February 13, 2016
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancerKyle C Strickland, Brooke E Howitt, Sachet A Shukla, et al.
Cancer Research|May 17, 2003
Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2Hideyuki Ikeda, Maiko Matsushita, Quinten Waisfisz, et al.
Nature Cancer|June 28, 2021
A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient TumorsJia Zhou, Camille Gelot, Constantia Pantelidou, et al.
Current Topics in Medicinal Chemistry|November 22, 2012
Docking, synthesis and anti-diabetic activity of novel sulfonylhydrazone derivatives designed as PPAR-gamma agonistsGisele Zapata-Sudo, Lídia M Lima, Sharlene L Pereira, et al.
DNA Repair|September 10, 2019
Functional profiling of nucleotide Excision repair in breast cancerAnne S Rajkumar-Calkins, Raphael Szalat, Matija Dreze, et al.
Blood|September 24, 2004
Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathwayJean Soulier, Thierry Leblanc, Jérôme Larghero, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancerNicole A Traphagen, Esmé Wheeler, Rong Li, et al.
The Journal of Clinical Investigation|August 9, 2016
Biallelic inactivation of REV7 is associated with Fanconi anemiaDominique Bluteau, Julien Masliah-Planchon, Connor Clairmont, et al.
Pageof 34